Zinc-finger nuclease editing of human cxcr4 promotes HIV-1 CD4(+) T cell resistance and enrichment.
about
Newer gene editing technologies toward HIV gene therapyDiversity and Inter-Connections in the CXCR4 Chemokine Receptor/Ligand Family: Molecular PerspectivesBone Marrow Gene Therapy for HIV/AIDSStudies of retroviral infection in humanized miceT-cell therapies for HIVExpanding the scope of site-specific recombinases for genetic and metabolic engineeringRecent developments in human immunodeficiency virus-1 latency researchNew generation humanized mice for virus research: comparative aspects and future prospectsGene therapy strategies for HIV/AIDS: preclinical modeling in humanized miceTargeted gene disruption to cure HIVLentivirus-mediated Gene Transfer in Hematopoietic Stem Cells Is Impaired in SHIV-infected, ART-treated Nonhuman Primates.Engineering T Cells to Functionally Cure HIV-1 InfectionProspects for treatment of latent HIV.Genome-Edited T Cell Therapies.Combinatorial anti-HIV gene therapy: using a multipronged approach to reach beyond HAARTImproved cell-penetrating zinc-finger nuclease proteins for precision genome engineeringGenome editing strategies: potential tools for eradicating HIV-1/AIDS.RNA interference approaches for treatment of HIV-1 infectionCombined Antiviral Therapy Using Designed Molecular Scaffolds Targeting Two Distinct Viral Functions, HIV-1 Genome Integration and Capsid AssemblyGenome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection.The clinical applications of genome editing in HIV.Altering cell death pathways as an approach to cure HIV infection.Efficient Modification of the CCR5 Locus in Primary Human T Cells With megaTAL Nuclease Establishes HIV-1 Resistance.Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection.A Cas9 Ribonucleoprotein Platform for Functional Genetic Studies of HIV-Host Interactions in Primary Human T Cells.Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice.Advances in targeted genome editing.Creating genetic resistance to HIV.HIV/AIDS: modified stem cells in the spotlight.Potential mechanisms for cell-based gene therapy to treat HIV/AIDS.Cell therapies for treatment of human immunodeficiency virus infection.Personalized gene therapy locks out HIV, paving the way to control virus without antiretroviral drugs.Cell-based gene therapy against HIV.Developmental history and application of CRISPR in human disease.Stem cell-based therapies for HIV/AIDS.T-cell therapies for HIV: Preclinical successes and current clinical strategies.Enhanced gene disruption by programmable nucleases delivered by a minicircle vector.Engineering Therapeutic T Cells: From Synthetic Biology to Clinical Trials.Novel AIDS therapies based on gene editing.Generation of an HIV resistant T-cell line by targeted "stacking" of restriction factors.
P2860
Q24631042-264309FE-ACD2-4C29-A20A-39F0225C37CCQ26782778-093CD0C9-BDD6-4CC3-A3EA-FADDB9C99352Q26801765-3CA8CFE5-4AAE-418E-96D9-79351E1978DCQ26849806-03BBAC58-0C41-452D-AD7F-53A93EF94E9FQ26866079-CAE77C96-AD5F-4E6A-A7D3-84C6FEC261FBQ26995224-4AE0374C-AD05-479A-9144-A0F07A72E144Q27013114-B3842631-4682-4079-8802-DDF65676338BQ27014786-595583E6-0E45-49FD-B304-6C1886A80F3EQ27022347-2F770D07-3776-4456-BA6F-BA91DAFC5E09Q27023171-CAC5BE4C-4A83-49DF-929A-4234977F155BQ27318042-A84A4318-7B30-437D-ACD4-AFF3500B7E5AQ28086801-9B4846C0-80E5-450A-B3FB-46AF89DC9232Q30424413-1F248540-BC1B-4D7F-9A01-ABFAEF168EADQ33729598-21CAFF7C-DC68-4E65-9F50-C8446E7A5CADQ34647798-71CA5974-6238-4288-B25D-3EC42158B910Q35161372-00C69F2A-2CBF-497B-93A7-C5834BF3986DQ35612053-948E6EDC-83EF-4F95-A37A-F43625933BE2Q35652119-173B7700-5574-40FD-A785-92FABEFEEB01Q36030091-D48223EA-328E-40E4-83E0-1E444EABCB41Q36181852-782B3761-6ED3-47A6-B820-2646CCB2CCCBQ36942032-DA5187AE-9246-4B14-B41B-F5DDE4630B4BQ37062057-F3279E42-2545-40B4-883A-60565CD4E93AQ37256197-589ABCB0-1A1D-4F4D-A86F-62EB1C6353F2Q37429714-0203A921-80D6-47E2-A485-7BB136059B70Q37441674-E0931D08-0AF0-4CFF-8396-EA50FA5BCCD7Q37593222-1EC5D3BF-9FC0-4FCE-BD27-818DB81AC4E9Q38028180-8EADAF6A-4005-44A0-AB70-CEFAB2DAD424Q38044070-0FBB1789-809D-4070-8324-5734E4FB20E4Q38186557-B4716A4E-C520-4610-9E45-225F77157F74Q38267240-CFD450C4-7230-48AC-885E-196093CFC7CEQ38366376-14BB4DFA-B334-41EA-853A-436388935E2DQ38462651-25E80C0A-16D5-45D3-A015-F5DF545E91B6Q38529069-A95874D5-FE70-466C-83CA-23C6378ADF9BQ38669948-C134E09C-7D5E-4554-94DF-C50464DF4883Q38827119-A3DE8E19-FFB7-4FF4-A3E3-17BF604F3BBAQ38856090-047DC23C-56D9-4C09-9434-51D2FF8F2AEFQ38964283-9E3BFA8C-AB81-4201-B8BC-023667690721Q39037477-EBD9913C-E3EB-476D-B2DA-A4F37EE626BAQ39140209-28F523CD-B1DF-4A76-91ED-7B51C182457BQ39203103-925FCABD-F0F9-4E13-9557-9E8D8E757999
P2860
Zinc-finger nuclease editing of human cxcr4 promotes HIV-1 CD4(+) T cell resistance and enrichment.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Zinc-finger nuclease editing o ...... ell resistance and enrichment.
@ast
Zinc-finger nuclease editing o ...... ell resistance and enrichment.
@en
type
label
Zinc-finger nuclease editing o ...... ell resistance and enrichment.
@ast
Zinc-finger nuclease editing o ...... ell resistance and enrichment.
@en
prefLabel
Zinc-finger nuclease editing o ...... ell resistance and enrichment.
@ast
Zinc-finger nuclease editing o ...... ell resistance and enrichment.
@en
P2093
P2860
P356
P1433
P1476
Zinc-finger nuclease editing o ...... ell resistance and enrichment.
@en
P2093
Bruce E Torbett
Colleen Fearns
Jianbin Wang
Jinyun Yuan
Karen Crain
Kenneth A Kim
Kevin L Hua
Michael C Holmes
Philip D Gregory
P2860
P304
P356
10.1038/MT.2011.310
P577
2012-01-24T00:00:00Z